Phio Pharmaceuticals Corp.
PHIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533040
In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Phio Pharmaceuticals Corp. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 668.5K | 647.1K | −21.4K (−3.2%) |
| Value | $815.0K | $662.6K | −$152.4K (−18.7%) |
New holders (4)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nomura Asset Management International Inc. | 50,000 | $51.0K | 0.00% |
| Citadel Advisors LLC | 47,150 | $48.3K | 0.00% |
| Bridgeway Capital Management, LLC | 12,000 | $12.3K | 0.00% |
| Barclays PLC | 231 | $237 | 0.00% |
Sold out (4)
Institutions that held Phio Pharmaceuticals Corp. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Scientech Research LLC | 30,032 | $36.6K |
| Gsa Capital Partners LLP | 19,864 | $24.0K |
| Two Sigma Securities, LLC | 15,224 | $18.6K |
| NBC Securities, Inc. | 1,074 | $1.31K |